MedPath

ENERGENESIS BIOMEDICAL CO., LTD.

ENERGENESIS BIOMEDICAL CO., LTD. logo
๐Ÿ‡น๐Ÿ‡ผTaiwan
Ownership
Public
Established
2012-01-01
Employees
11
Market Cap
-
Website
http://www.energenesis-biomedical.com

Clinical Trials

4

Active:0
Completed:2

Trial Phases

2 Phases

Phase 2:3
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)โ€ข Click on a phase to view related trials

Phase 2
3 (75.0%)
Phase 3
1 (25.0%)

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

Phase 3
Recruiting
Conditions
Diabetic Foot Ulcer
Foot Ulcer
Diabetes Mellitus
Wound
Interventions
Drug: ENERGI-F703 GEL
Drug: ENERGI-F703 matched vehicle
First Posted Date
2023-07-05
Last Posted Date
2025-10-02
Lead Sponsor
Energenesis Biomedical Co., Ltd.
Target Recruit Count
230
Registration Number
NCT05930210
Locations
๐Ÿ‡บ๐Ÿ‡ธ

A and D Doctor Center, Miami, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Bioclinical Research, Miami, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Reliant Medical Research, Miami, Florida, United States

and more 21 locations

A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer

Phase 2
Recruiting
Conditions
Venous Leg Ulcer
Interventions
Drug: ENERGI-F703 GEL matched vehicle
Drug: ENERGI-F703 GEL
First Posted Date
2019-09-06
Last Posted Date
2024-02-20
Lead Sponsor
Energenesis Biomedical Co., Ltd.
Target Recruit Count
80
Registration Number
NCT04078555
Locations
๐Ÿ‡จ๐Ÿ‡ณ

Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan

ENERGI-F701 for Female Hair Loss Treatment

Phase 2
Completed
Conditions
Hair Loss
Female Pattern Baldness
Alopecia
Interventions
First Posted Date
2017-11-22
Last Posted Date
2020-11-24
Lead Sponsor
Energenesis Biomedical Co., Ltd.
Target Recruit Count
67
Registration Number
NCT03351322
Locations
๐Ÿ‡จ๐Ÿ‡ณ

Taipei Veterans General Hospital, Taipei, Taiwan

ENERGI-F703 for Diabetic Foot Ulcers Phase II Study

Phase 2
Completed
Conditions
Diabetic Foot
Foot Ulcer
Diabetes Mellitus
Wounds
Interventions
Drug: ENERGI-F703 matched vehicle
First Posted Date
2016-02-03
Last Posted Date
2020-11-24
Lead Sponsor
Energenesis Biomedical Co., Ltd.
Target Recruit Count
141
Registration Number
NCT02672436
Locations
๐Ÿ‡จ๐Ÿ‡ณ

Tri-Service General Hospital, Taipei, Taiwan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.